Effective Use of ALK Inhibitors in EML4::ALK-Positive Lymphatic Malformations

Beth Apsel Winger1,2, Christopher F Dowd3, Kristin A Shimano2

  • 1Department of Clinical Pharmacy, UCSF, San Francisco, California, USA.

Pediatric Blood & Cancer
|November 12, 2024
PubMed